NanoViricides Inc. (NNVC)

[robi-1-kenobi]

FluCide is most important. Period. Full Stop. GLP Regulatory Tox and Safety testing on FluCide is needed now.

EbolaCide2 may be important - if and only if they can work on it without impacting FluCide. It could provide an important proof of concept.

However, we should be aware of the following. FDA and other countries' regulations on compassionate and emergency use generally require data from GLP Regulatory Tox on multiple species of animals with PK/ADME to determine the safe and effective dosing - at a minimum. NNVC HAS NOT done this yet for even FluCide, let alone EbolaCide2 (although EC2 may potentially leverage some of FluCide data when that is done).

Maybe the situation gets desperate enough in some countries to allow use of medicines with less safety data - but that is a very long shot.

More importantly, however, EbolaCide2 could also provide another source of funds (GAs, NGAs, industry partners) to further work on Ebola and Marburg and other filoviruses that do have larger markets and may qualify for Orphan Drug status with the possibility of Priority Review Vouchers that could be worth tens to hundreds of millions of dollars to NNVC from big pharma companies.

One other possibility - share price run up for NNVC over the sensationalistic coverage of the disease with progress on EbolaCide2. However much of this would likely be from weak hands and may not result in much sustainable price increase.

Lousy Engineer quote:

Don't know why everyone is fixated on Ebolacide- the reality is there's not much money to be made from Ebola.